Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Infinity Pharmaceuti (NQ: INFI)
2.070 USD  +0.090 (+4.55%)
Official Closing Price  /  Updated: 4:00 PM EDT, Aug 14, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 316,200
Open 2.020
Bid (Size) 1.650 (1)
Ask (Size) 2.350 (3)
Prev. Close 1.980
Today's Range 1.885 - 2.080
52wk Range 0.9255 - 3.750
Shares Outstanding 56,069,632
Dividend Yield N/A
Performance
YTD
-7.17%
-7.17%
1 Month
+1.47%
+1.47%
3 Month
-1.43%
-1.43%
6 Month
+15.00%
+15.00%
1 Year
+86.49%
+86.49%
Top News
More News
Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results
- Dr. Samuel Agresta Appointed as Chief Medical Officer - Read More
from PR Newswire
Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer
- Key Addition to Infinity's Clinical Development Team Brings Recent Experience Leading First-in-Class, Targeted Oncology Programs Through FDA Approvals - Read More
from PR Newswire
More News
Read More
Infinity Announces The Date Of Its Second Quarter 2018 Financial Results Conference Call And Webcast
from PR Newswire
Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies
from PR Newswire
New Research: Key Drivers of Growth for CNA Financial, AutoNation, Hess, Infinity Pharmaceuticals, Regulus Therapeutics, and Weyerhaeuser — Factors of Influence, Major Initiatives and Sustained Produc
from GlobeNewswire News Releases
Infinity Reports IPI-549 Clinical and Translational Data from Ongoing Phase 1/1b Study at American Society of Clinical Oncology Annual Meeting
from PR Newswire
Infinity Announces Presentations On IPI-549 At Upcoming American Society of Clinical Oncology Annual Meeting
from PR Newswire
Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results
from PR Newswire
Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies
from Business Wire News Releases
Infinity Announces The Date Of Its First Quarter 2018 Financial Results Conference Call And Webcast
from PR Newswire
Serametrix MDSC Assay Being Utilized By Infinity Pharmaceuticals in the First Clinical Study to Prospectively Identify Patients With High Blood Levels of MDSCs
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.